drug
GABAPENTIN
Marketedupdated 6mo agoby ACI Healthcare USA Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval240 co-mentions · 120 sources
- drugGralise127 co-mentions · 127 sources
- drugNeurontin127 co-mentions · 127 sources
- tagSmall Molecule120 co-mentions · 120 sources
- companyActavis Elizabeth LLC18 co-mentions · 18 sources
- companyStrides Pharma Inc13 co-mentions · 13 sources
- tagRecall7 co-mentions · 7 sources
- companySun Pharmaceutical Industries Ltd6 co-mentions · 2 sources
indications
investigational
Epilepsy
all catalysts(59)
approval · 59
Sep 12, 2003
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 6, 2005
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 8, 2005
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 23, 2005
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 5, 2006
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
May 13, 2010
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 11, 2011
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jun 24, 2011
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jun 24, 2011
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Aug 30, 2011
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 11, 2012
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 11, 2012
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Aug 28, 2012
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 8, 2014
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 8, 2014
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 16, 2015
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 13, 2016
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 13, 2016
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 24, 2017
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
May 14, 2018
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 16, 2018
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 16, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 16, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 2, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 2, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 26, 2021
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 9, 2021
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 20, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 9, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 3, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 7, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 7, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 4, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 4, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 19, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 24, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 17, 2025
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 29, 2026
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 29, 2026
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 6, 2026
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 2, 2026
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Trials studying GABAPENTIN
- phase4Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug-Dependent, Recreational Opioid Users
- —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- —A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
- phase1A Study on Ketoprofen Lysine Salt (KLS) + Gabapentin (GABA) vs KLS to Investigate Their Pharmacodynamic in Healthy Males
- phase4A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
- phase4Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairment
- phase2Effect of PP-01 on Cannabis Withdrawal Syndrome
- phase4An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Users
News(1)
- Most people haven’t heard of kratom. What is it, and who’s using it?Few Americans are familiar with kratom, despite public health messaging and rising use. So what is it, and who's using it?stat · 12d ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that